Birchview Capital »

Novo Nordisk A/S shares owned by Birchview Capital

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Birchview Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 24k 47.94

More positions owned by Birchview Capital

Kla Corporation Com New (KLAC)
Bristol Myers Squibb (BMY)
Lam Research Corporation Com New (LRCX)
Solid Biosciences Com New (SLDB)
Intellia Therapeutics (NTLA)
Biodesix
Stoke Therapeutics (STOK)
Encana Corporation (OVV)
Nektar Therapeutics (NKTR)
Corcept Therapeutics Incorporated (CORT)
Neurocrine Biosciences (NBIX)
Prothena Corp SHS (PRTA)
ACADIA Pharmaceuticals (ACAD)
Protagonist Therapeutics (PTGX)
Compass Therapeutics (CMPX)

View all positions for Birchview Capital

Top funds holding Novo Nordisk A/S

Susquehanna International
Dodge & Cox
Citadel Advisors
Loomis, Sayles and
Franklin Resources
Goldman Sachs Group
Jane Street
Bank of America Corporation
T. Rowe Price Associates
Morgan Stanley
Capital Research and Management Company - Division 3
Folketrygdfondet
D. E. Shaw & Co
Fisher Investments
Arrowstreet Capital, Limited Partnership

View all funds holding Novo Nordisk A/S